Eli Lilly just shared some new information. That data suggests it has an advantage against Novo Nordisk in a key market.
Eli Lilly & Co. approved a program to buy back as much as $15 billion of its own shares amid rapid growth fueled in part by ...
One particular healthcare stock has shown its ability to soar on good news -- and it's had plenty of it. This year the ...
Zepbound outperformed Wegovy for weight loss in a new clinical trial funded by Eli Lilly & Co., Zepbound's maker.
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Eli Lilly and Company (LLY), AbbVie ...
BioAge Labs Inc. (NASDAQ:BIOA) announced that it will discontinue the ongoing STRIDES Phase 2 study of its investigational ...
After a lucrative IPO in September, Richmond-based BioAge is seeing its biotech fortunes shift with its stock falling over 70 ...
Joe Breen, 38, is one of thousands of people whose experiences with GLP-1s such as Ozempic and Wegovy have radically changed ...
CBS News reports that workplace violence at Allina Health's Abbott Northwestern Hospital has led to more than $83,000 in fines over the past year. Other news from the health industry is on the demand ...
Delta, a global leader in power management and IoT-based smart green solutions, has joined the National Parks Board of ...
The fighters who forced Bashar al-Assad into exile began the complex task of governing the Syrian capital. New York Times reporters entering the country saw relics of the deposed regime on the ...
Phuket is a province in the south of Thailand. Phuket's beaches face the Andaman Sea allowing the west coast beaches fantastic sunsets right throughout the year. If ...